Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump
Go back to Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump| Medtronic Inc. (NYSE: MDT) | Delayed: 86.29 -0.8 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.09 | 52 Week High | $89.27 | |||
| Open | $86.57 | 52 Week Low | $71.03 | |||
| Day High | $87.42 | P/E | 24.51 | |||
| Day Low | $86.20 | EPS | $3.52 | |||
| Volume | 26,690,904 | |||||
